Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionCss Llc/il
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Css Llc/il ownership in 1VRTX / Vertex Pharmaceuticals Incorporated

On May 15, 2025 - Css Llc/il filed a 13F-HR form disclosing ownership of 0 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $0 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 18, 2025 disclosing 550 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Css Llc/il has a history of taking positions in derivatives of the underlying security (1VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 600 of underlying shares valued at $267,924 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -550 -100.00 0 -100.00
2025-02-18 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 550 -450 -45.00 221 -52.47 0.0098
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,000 300 42.86 465 41.77 0.0213
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 700 0 0.00 328 12.33 0.0168
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 700 -18,000 -96.26 293 -96.16 0.0169
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 18,700 -300 -1.58 7,609 15.15 0.4397
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,000 -300 -1.55 6,607 -2.71 0.4335
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,300 1,300 7.22 6,792 19.75 0.4203
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 18,000 13,336 285.93 5,671 321.32 0.3743
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,664 1,017 27.89 1,347 27.46 0.0762
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,647 -136 -3.60 1,056 -0.94 0.0497
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,783 1,134 42.81 1,066 54.27 0.0435
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,649 1,149 76.60 691 110.03 0.0250
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,500 -47,560 -96.94 329 -96.30 0.0117
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 49,060 16,744 51.81 8,899 36.57 0.3787
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 32,316 32,316 6,516 0.2698
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -600 -100.00 0 -100.00
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 600 600 143 0.0113
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 26,200 11.02 7,566 10.73 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 23,600 0.00 6,833 2.75 n/a n/a n/a
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM Call 23,600 -48.70 6,650 -44.60 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 46,000 45,900.00 12,004 54,463.64 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 100 22 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 300 60 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 2,500 595 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 600 268 n/a n/a n/a
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 1,000 445 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 18,000 0.00 7,324 17.02 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 18,000 0.00 6,259 -1.18 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 18,000 0.00 6,334 11.69 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 18,000 620.00 5,671 686.55 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 2,500 722 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Put 51,100 6.90 9,269 -3.82 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 47,800 9,637 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.